Access cutting-edge epidermolysis bullosa treatment through this clinical trial at a research site in San Antonio. Study-provided care at no cost to qualified participants.
Access epidermolysis bullosa specialists in San Antonio at no cost
This study follows strict safety protocols and ethical guidelines
All study-related epidermolysis bullosa treatment provided free
KB803-EYE-01 is a Phase 3 double-blind, intra-patient crossover study, to evaluate the safety and efficacy of KB803 versus matched placebo in pediatric and adult subjects with recurrent corneal abrasions due to dystrophic epidermolysis bullosa (DEB).
Sponsor: Krystal Biotech, Inc.
Check if you qualify for this epidermolysis bullosa clinical trial in San Antonio, TX
If you're searching for epidermolysis bullosa treatment options in San Antonio, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Antonio research site is actively enrolling participants for this clinical trial. You'll receive care from experienced epidermolysis bullosa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.